The dynamic of pH, hydrogen peroxide and nitrite in exhaled breath condensate from patients with COPD and asthma exacerbation
T. Anokhina, E. Anaev, A. Karyakin, V. Apyari, S. Dmitrienko, A. Chuchalin (Moscow, Russian Federation)
Source: Annual Congress 2010 - COPD: treatment and monitoring
Session: COPD: treatment and monitoring
Session type: Thematic Poster Session
Number: 1330
Disease area: Airway diseases
Abstract The analysis of exhaled breath condensate (EBC) biomarkers is non-invasive method for evaluation of the oxidative stress and inflammation in the respiratory tract of patients with pulmonary diseases.The aim: To evaluate the dynamic of pH-level, the concentration of hydrogen peroxide (H2 O2 ) and nitrite (NO2 - ) in EBC from patients with COPD and asthma exacerbation before and after 14 days treatment.Methods: We enrolled 28 patients (14 – COPD and 14 – asthma) and 14 healthy nonsmokers. EBC was collected using ECoScreen before and after 14-days treatment. pH level was measured using Beckman microelectrode. H2 O2 concentration in EBC was detected using Prussian Blue based sensor. NO2 - concentration in EBC was measured by modified Griess reaction. Spirometry was evaluated also.Results: The pH was decreased and H2 O2 was increased in EBC from patients with COPD and asthma exacerbation in compared with healthy subjects (p<0.05). NO2 - in EBC was decreased in all groups of patients, but significant difference was only in the group of asthma compared with healthy (p=0.005). After treatment there were significant increase of pH and decrease of H2 O2 in EBC from patients with COPD and asthma, but NO2 - wasn‘t significant changed. Negative correlation was found between H2 O2 and NO2 - in EBC from asthma patients (r=-0.64). No correlations were found between dynamic of biomarkers in EBC and dynamic of lung function parameters.Conclusion: Determination of EBC biomarkers helpS to assess inflammatory activity in the respiratory tract of patients with COPD and asthma exacerbation and effect of treatment.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Anokhina, E. Anaev, A. Karyakin, V. Apyari, S. Dmitrienko, A. Chuchalin (Moscow, Russian Federation). The dynamic of pH, hydrogen peroxide and nitrite in exhaled breath condensate from patients with COPD and asthma exacerbation. Eur Respir J 2010; 36: Suppl. 54, 1330
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Elevated concentration of exhaled hydrogen peroxide in patients with asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 166s Year: 2001
Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
pH in exhaled breath condensate of patients with stable and unstable asthma Source: Eur Respir J 2004; 24: Suppl. 48, 508s Year: 2004
Concentrations of the hydrogen peroxide and nitrite in exhaled breath condensate as markers of inflammatory lung diseases Source: Annual Congress 2008 - COPD Year: 2008
Correlation of H2 O2 , pH and nitrite/nitrate in exhaled breath condensate and systemic inflammatory parameters during and after acute COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 349s Year: 2005
The airways are the main source of hydrogen peroxide in exhaled breath condensate Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010
Exhaled breath condensate pH Source: Eur Respir Monogr 2010; 49: 173-182 Year: 2010
Relationship between hydrogen peroxide levels in exhaled breath condensate and long term changes in small airway function of patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 585s Year: 2007
Exhaled breath condensate: hydrogen peroxide Source: Eur Respir Monogr 2010; 49: 162-172 Year: 2010
8-isoprostane in breath condensate in patients with exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate Source: Eur Respir J 2004; 23: 189-192 Year: 2004
8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
Evaluation of hydrogen perioxide in breath condensate in children with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002
pH in exhaled breath condensate of patients with inflammatory airway diseases Source: Eur Respir J 2003; 22: Suppl. 45, 240s Year: 2003
Increased concentration of hydrogen peroxide (H2 O2 ) in expired breath condensate of patients with lung cancer and stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001
Exercise increases the hydrogen peroxide release in exhaled breath condensate Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012
Reproducibility of exhaled breath condensate pH in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 468s Year: 2004
Nitrite/nitrate in exhaled breath condensate (EBC) of patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006
Conductivity and pH in exhaled breath condensate of stable asthmatic children Source: Eur Respir J 2006; 28: Suppl. 50, 789s Year: 2006